rs2305081

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001845.6(COL4A1):​c.2716+99C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.148 in 1,267,340 control chromosomes in the GnomAD database, including 14,823 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1551 hom., cov: 32)
Exomes 𝑓: 0.15 ( 13272 hom. )

Consequence

COL4A1
NM_001845.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.23

Publications

4 publications found
Variant links:
Genes affected
COL4A1 (HGNC:2202): (collagen type IV alpha 1 chain) This gene encodes a type IV collagen alpha protein. Type IV collagen proteins are integral components of basement membranes. This gene shares a bidirectional promoter with a paralogous gene on the opposite strand. The protein consists of an amino-terminal 7S domain, a triple-helix forming collagenous domain, and a carboxy-terminal non-collagenous domain. It functions as part of a heterotrimer and interacts with other extracellular matrix components such as perlecans, proteoglycans, and laminins. In addition, proteolytic cleavage of the non-collagenous carboxy-terminal domain results in a biologically active fragment known as arresten, which has anti-angiogenic and tumor suppressor properties. Mutations in this gene cause porencephaly, cerebrovascular disease, and renal and muscular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2014]
COL4A1 Gene-Disease associations (from GenCC):
  • brain small vessel disease 1 with or without ocular anomalies
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Ambry Genetics, PanelApp Australia, Orphanet, Genomics England PanelApp
  • autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Ambry Genetics
  • microangiopathy and leukoencephalopathy, pontine, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • familial porencephaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • pontine autosomal dominant microangiopathy with leukoencephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • retinal arterial tortuosity
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 13-110177743-G-A is Benign according to our data. Variant chr13-110177743-G-A is described in ClinVar as [Benign]. Clinvar id is 1225740.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.16 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL4A1NM_001845.6 linkc.2716+99C>T intron_variant Intron 33 of 51 ENST00000375820.10 NP_001836.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL4A1ENST00000375820.10 linkc.2716+99C>T intron_variant Intron 33 of 51 1 NM_001845.6 ENSP00000364979.4 P02462-1

Frequencies

GnomAD3 genomes
AF:
0.131
AC:
19871
AN:
151768
Hom.:
1547
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0533
Gnomad AMI
AF:
0.376
Gnomad AMR
AF:
0.165
Gnomad ASJ
AF:
0.201
Gnomad EAS
AF:
0.126
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.130
Gnomad MID
AF:
0.146
Gnomad NFE
AF:
0.163
Gnomad OTH
AF:
0.136
GnomAD4 exome
AF:
0.151
AC:
168034
AN:
1115454
Hom.:
13272
AF XY:
0.150
AC XY:
85809
AN XY:
570436
show subpopulations
African (AFR)
AF:
0.0483
AC:
1300
AN:
26936
American (AMR)
AF:
0.191
AC:
8094
AN:
42418
Ashkenazi Jewish (ASJ)
AF:
0.190
AC:
4522
AN:
23760
East Asian (EAS)
AF:
0.0857
AC:
3224
AN:
37626
South Asian (SAS)
AF:
0.141
AC:
11021
AN:
78314
European-Finnish (FIN)
AF:
0.139
AC:
6725
AN:
48466
Middle Eastern (MID)
AF:
0.159
AC:
564
AN:
3546
European-Non Finnish (NFE)
AF:
0.156
AC:
125363
AN:
805300
Other (OTH)
AF:
0.147
AC:
7221
AN:
49088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
7599
15199
22798
30398
37997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3772
7544
11316
15088
18860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.131
AC:
19881
AN:
151886
Hom.:
1551
Cov.:
32
AF XY:
0.131
AC XY:
9742
AN XY:
74216
show subpopulations
African (AFR)
AF:
0.0532
AC:
2205
AN:
41458
American (AMR)
AF:
0.166
AC:
2528
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.201
AC:
696
AN:
3466
East Asian (EAS)
AF:
0.125
AC:
642
AN:
5118
South Asian (SAS)
AF:
0.146
AC:
700
AN:
4806
European-Finnish (FIN)
AF:
0.130
AC:
1365
AN:
10506
Middle Eastern (MID)
AF:
0.143
AC:
42
AN:
294
European-Non Finnish (NFE)
AF:
0.163
AC:
11078
AN:
67954
Other (OTH)
AF:
0.134
AC:
284
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
856
1712
2569
3425
4281
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.154
Hom.:
3356
Bravo
AF:
0.130
Asia WGS
AF:
0.111
AC:
386
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jul 05, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
0.91
DANN
Benign
0.53
PhyloP100
-2.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2305081; hg19: chr13-110830090; API